{
    "2019-05-09": [
        [
            {
                "time": "2019-05-09",
                "original_text": "Drug Prices Will Be Included In TV Ads Under New Trump Admin Rule",
                "features": {
                    "keywords": [
                        "Drug",
                        "Prices",
                        "TV",
                        "Ads",
                        "Trump",
                        "Admin",
                        "Rule"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-09",
                "original_text": "Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up",
                "features": {
                    "keywords": [
                        "Perrigo",
                        "PRGO",
                        "Q1",
                        "Earnings",
                        "Sales",
                        "Stock",
                        "Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-09",
                "original_text": "Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "ABIO",
                        "AGEN",
                        "ENDP",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-09",
                "original_text": "These 3 revolutionary genomics companies are changing lives for patients â€” and investors",
                "features": {
                    "keywords": [
                        "revolutionary",
                        "genomics",
                        "companies",
                        "changing",
                        "lives",
                        "patients",
                        "investors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-09",
                "original_text": "Takeda sheds products, 485 jobs in deals worth $5.7B",
                "features": {
                    "keywords": [
                        "Takeda",
                        "sheds",
                        "products",
                        "jobs",
                        "deals",
                        "$5.7B"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}